Physician profile
Eric Oliver
NPI 1912168113
$31,183.11
in general payments reported to CMS, 2019-2025
5 companies · $5,019 in 2025
The $5,019 reported for 2025 was more than what 86% of Allergy & Immunology (Internal Medicine) providers received nationally (typical 2025 total: $681).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,843 · 2020: $8,400 · 2023: $16K · 2025: $5,019.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $17K · Travel and Lodging: $2,174 · Food and Beverage: $1,264 · Education: $52.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $17,450.00 |
| Travel and Lodging | $2,173.76 |
| Food and Beverage | $1,263.55 |
| Education | $52.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $11,576.14 | 2023-2025 | |
| Regeneron Healthcare Solutions, INC. | $9,311.17 | 2023 | Dupixent |
| Eli Lilly Export S.A. Puerto Rico Branch | $8,400.00 | 2020 | |
| Eli Lilly and Company | $1,842.81 | 2019 | |
| Sanofi-Aventis U.S. LLC | $52.99 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Oliver listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.